Arbutus Terminates mRESVIA Agreement with Genevant

Genevant will pay Arbutus a $1 million termination fee following the termination of the mRESVIA Agreement as part of the broader patent settlement with Moderna. This action clarifies recovery rights and finalizes terms under the new settlement.